Oxidative stress in chronic hepatitis C: not just a feature of late stage disease

2002 ◽  
Vol 36 (6) ◽  
pp. 805-811 ◽  
Author(s):  
Sanjiv K. Jain ◽  
Philip W. Pemberton ◽  
Alexander Smith ◽  
Raymond F.T. McMahon ◽  
Peter C. Burrows ◽  
...  

2016 ◽  
Vol 53 ◽  
pp. 106-107
Author(s):  
B.A.M. El Awady ◽  
B. Hussein ◽  
E. El-Seidi ◽  
Y. Abou-Hamed


2015 ◽  
Vol 87 (2) ◽  
pp. 49 ◽  
Author(s):  
I. A. Bulatova ◽  
Yu. I. Tretyakova ◽  
V. V. Shchekotov ◽  
A. P. Shchekotova ◽  
P. V. Ulitina ◽  
...  


2004 ◽  
Vol 6 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Sabina Mahmood ◽  
Miwa Kawanaka ◽  
Ayumi Kamei ◽  
Akiyoshi Izumi ◽  
Keiichi Nakata ◽  
...  




2009 ◽  
Vol 23 (S1) ◽  
Author(s):  
Isaias Dichi ◽  
Danielle Venturini ◽  
Andrea Colado Simão ◽  
Décio Sabbatini Barbosa ◽  
Edson Lopes Lavado ◽  
...  


2009 ◽  
pp. 1-8
Author(s):  
Ana Oliveira ◽  
Edison Parise ◽  
Regina Catarino ◽  
Valeria Lanzoni ◽  
Mariliza Leite-Mor ◽  
...  


2003 ◽  
Vol 17 (11) ◽  
pp. 644-650 ◽  
Author(s):  
Fátima Serejo ◽  
Ingrid Emerit ◽  
Paulo Manuel Filipe ◽  
Afonso Camilo Fernandes ◽  
Maria Adília Costa ◽  
...  

AIMS: To evaluate the oxidative stress parameters before, during and after interferon treatment.PATIENTS/METHODS: Twenty patients were treated with interferon α2b 5 MU, three times a week, subcutaneously, for 12 months. Liver biopsy was performed six months before treatment and at the six month follow-up. Chromosomal breakage studies were evaluated by the adjusted clastogenic score (ACS, normal value [nv] 1.1±2.4%). Plasma malondialdehyde (MDA) was measured according to the Yagi method (nv 6.6±1.4 nmol/mL) and total thiols using the Ellman’s reagent (DTNB) (nv 9.8±1.3 µmol/g protein). A serum marker of fibrogenesis, the amino-terminal propeptide of Procollagen type III (PIIIP), was quantified by radioimmunoassay (nv 0.37±0.18 U/L).RESULTS: Compared with reference samples, the plasma of patients before treatment showed an increase of ACS (9.2±3.2%, P<0.001); higher MDA values (12.6±2.7nmol/mL, P<0.001) and total plasma sulfhydryl groups (t-SH) were decreased (6.3±1.1 µmol/g protein, P<0.001). During treatment and at the follow-up, a decrease in ACS was noticed in all patients (P<0.001), but without normalization; a decrease in MDA was seen, with progressive normalization until the end of the follow up only in sustained responders (P<0.003), while an increase of t-SH was seen, with progressive normalization until the end of follow up in all patients (P<0.005). A positive correlation of ACS with grading of inflammation was found (r=0.52, P<0.03) but not with fibrosis staging. In contrast, plasma MDA correlates with fibrosis staging (r=0.51, P<0.03) and with PIIIP (r=0.57, P<0.03) but without grading of inflammation.CONCLUSIONS: The present study confirmed the presence of oxidative stress in chronic hepatitis C patients. Interferon promotes a long term inhibition of oxidative stress with concomitant improvement of activity and fibrosis. In the management of chronic hepatitis C, adjuvant therapy with antioxidants could be useful.



Nutrition ◽  
2016 ◽  
Vol 32 (3) ◽  
pp. 362-367 ◽  
Author(s):  
Jorge P. Sales de Almeida ◽  
Lucas Silva Liberatti ◽  
Fernanda Esteves Nascimento Barros ◽  
Ana Paula Kallaur ◽  
Marcell A. Batisti Lozovoy ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document